Biotech Patents and Applying the FDA Exemption to Research Tools

This publication provides a detailed analysis of the biotech industry, patent law, the need to protect the incentive to produce new inventions without stifiling competition or the development of follow through inventions and the concerns of the owners of biotech research tool owners. 

It is a detailed analysis of the industry, policies, players, and proposes a modification to the FDA Exemption from patent infringement to permit courts to appropriately balance the interests involved.  The paper covers a variety of topics and principles relating to patent law, biology, Food and Drug Administrtion Regulations, the pharmaceutical industry, competition and antitrust theory, litigation and business strategy.   

 Thanks and Enjoy!

A proposed modification to the FDA Exemption from Patent Infringement.

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s